Smoking cessation after long-term sick leave due to cancer in comparison with cardiovascular disease: Japan Epidemiology Collaboration on Occupational Health Study.
Cancer
Cardiovascular disease
Japan
Long-term sick leave
Smoking cessation
Journal
Industrial health
ISSN: 1880-8026
Titre abrégé: Ind Health
Pays: Japan
ID NLM: 2985065R
Informations de publication
Date de publication:
09 Jun 2020
09 Jun 2020
Historique:
pubmed:
16
10
2019
medline:
30
1
2021
entrez:
16
10
2019
Statut:
ppublish
Résumé
In occupational settings, smokers may take quitting smoking seriously if they experienced long-term sick leave due to cancer or cardiovascular disease (CVD). However, no study has elucidated the smoking cessation rate after long-term sick leave. We examined the smoking cessation rate after long-term sick leave due to cancer and CVD in Japan. We followed 23 survivors who experienced long-term sick leave due to cancer and 39 survivors who experienced long-term sick leave due to CVD who reported smoking at the last health exam before the leave. Their smoking habits before and after the leave were self-reported. Logistic regression was used to calculate adjusted smoking cessation rates. Smoking cessation rate after long-term sick leave due to cancer was approximately 70% and that due to CVD exceeded 80%. The adjusted smoking cessation rate was 67.6% (95% confidence interval [CI]: 47.0, 88.2) for cancer and 80.7% (95% CI: 67.7, 93.8) for CVD. Smoking cessation rate after a longer duration of sick leave (≥60 d) tended to increase for both CVD and cancer. Although any definite conclusion cannot be drawn, the data suggest that smoking cessation rate after long-term sick leave due to CVD is slightly higher than that for cancer.
Identifiants
pubmed: 31611479
doi: 10.2486/indhealth.2019-0136
pmc: PMC7286709
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
246-253Références
CA Cancer J Clin. 2016 Jul;66(4):271-89
pubmed: 27253694
Jpn J Clin Oncol. 2015 Sep;45(9):884-91
pubmed: 26142437
Br J Cancer. 2012 Sep 25;107(7):1195-202
pubmed: 22892390
Ann Fam Med. 2017 Sep;15(5):443-450
pubmed: 28893814
J Clin Epidemiol. 2009 Mar;62(3):306-13
pubmed: 18774692
Int J Epidemiol. 2014 Jun;43(3):962-70
pubmed: 24603316
Circulation. 2010 Apr 6;121(13):1518-22
pubmed: 20368531
Cancer Causes Control. 2008 Sep;19(7):689-701
pubmed: 18293090
Nihon Koshu Eisei Zasshi. 2016;63(12):758-768
pubmed: 28100895
J Clin Oncol. 2015 May 20;33(15):1647-52
pubmed: 25897151
Cancer Control. 2003 Jul-Aug;10(4):325-33
pubmed: 12915811
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Ann Behav Med. 2017 Feb;51(1):117-127
pubmed: 27670773
J Diabetes Investig. 2018 Sep;9(5):1052-1059
pubmed: 29380553
Langenbecks Arch Surg. 2008 Jul;393(4):535-45
pubmed: 18193270
Tob Control. 2018 Jul;27(e1):e25-e33
pubmed: 29248896
Int J Cancer. 2009 May 15;124(10):2406-15
pubmed: 19142968
PLoS One. 2015 Jul 22;10(7):e0132166
pubmed: 26200457
J Epidemiol. 2017 Dec;27(12):590-595
pubmed: 28648766
J Oncol Pract. 2016 Jan;12(1):55-8
pubmed: 26374860
J Gerontol B Psychol Sci Soc Sci. 2012 May;67(3):279-88
pubmed: 21983040
Health Psychol. 2002 May;21(3):263-72
pubmed: 12027032
BMJ. 2010 Jan 21;340:b5569
pubmed: 20093278
J Epidemiol Community Health. 2003 Oct;57(10):802-8
pubmed: 14573586
Nicotine Tob Res. 2016 Jun;18(6):1399-407
pubmed: 26438648
Nicotine Tob Res. 2009 Jan;11(1):12-24
pubmed: 19246437
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
J Clin Oncol. 2014 Nov 10;32(32):3593-5
pubmed: 25267760
Am J Epidemiol. 2001 Feb 1;153(3):299-306
pubmed: 11157418
Iran Red Crescent Med J. 2014 Jun;16(6):e18162
pubmed: 25068057